Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 5/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.30 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17816875 | 0.93 | LIPG (0.45) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL22402080 | 0.91 | LPL (0.37) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL23273089 | 0.90 | LIPG (0.47) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL29603064 | 0.90 | LIPG (0.44) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL17470489 | 0.90 | LIPG (0.44) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL17816784 | 0.89 | LIPG (0.43) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL12166505 | 0.88 | LIPG (0.43) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL22173457 | 0.87 | LIPG (0.52) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL20806383 | 0.86 | LIPG (0.43) | LPLLIPGESR1ESR2MEN1 | |
| SCHEMBL20964191 | 0.86 | LIPG (0.39) | LPLLIPGPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815418-B2 | Compound including fluorenyl group for organic photoelectric device and organic photoelectric device including the same | CHEIL INDUSTRIES, INC. (KR) | 2014-08-26 | — | — | US | disclosed |
| US-8815418-B2 | Compound including fluorenyl group for organic photoelectric device and organic photoelectric device including the same | CHEIL INDUSTRIES, INC. (KR) | 2014-08-26 | — | — | US | disclosed |
| EP-2431445-A2 | COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE COMPRISING SAME | Cheil Industries Inc. (KR) | 2012-03-21 | — | — | EP | disclosed |
| US-20120056171-A1 | COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | CHEIL INDUSTRIES, INC. (KR) | 2012-03-08 | — | — | US | disclosed |
| US-20120056171-A1 | COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | CHEIL INDUSTRIES, INC. (KR) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120056171-A1 | COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | PPOX, AOX1, DDT | LPL 2004/4885LIPG 2418/4885ESR1 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.